Drug treats hepatitis C by targeting body's RNA

03/27/2013 | Science News

A new compound drug could be effective in treating hepatitis C by attacking RNA that allows the virus to gain traction in a patient's body. The drug, miravirsen, targets the body's microRNA-122, preventing viral replication, according to findings published in the New England Journal of Medicine. The treatment could potentially also treat other serious diseases, including cancer. "This is really a revolution in science and it's now beginning to be translated into advances that control disease," said Phillip Sharp, an MIT molecular biologist who won a 1993 Nobel Prize for work on RNA.

View Full Article in:

Science News

Published in Briefs:

SmartBrief Job Listings for Education

Job Title Company Location
Business Development Analyst
Insight Education Group
Los Angeles, CA
Marketing Manager
Insight Education Group
Washington, DC or Los Angeles, CA
K-12 Teachers Needed at Int’l Schools
The International Educator
Multiple Locations
Account Executive
NWEA
Multiple Locations, SL_Multiple Locations
Professional Development (PD) Staff Trainer
NWEA
Multiple Locations, SL_Multiple Locations